TLR5 and chronic obstructive pulmonary disease: In conclusion, we can say that our results suggest that TLR5 could be potentially considered as a biomarker for COPD and LC development with functional relevance, which is reflected in increased sensitivity to chemotherapeutic drugs frequently applied in lung cancer treatment.